SecBot SecBot
Institutional Cluster

CGON

CG Oncology, Inc.
BULLISH
Impact 6/10
Horizonweeks Processed5mo ago
Institutional cluster: 14 buyers, 3 sellers (bullish)
Actionable Insight ▲ Bullish

The strong active-manager buying cluster, particularly Point72's massive increase, signals conviction in CG Oncology's pipeline catalysts. Monitor upcoming clinical data readouts and any insider selling that could indicate management taking advantage of the institutional demand. The 45-day 13F reporting lag means these positions may have already been adjusted, watch for Q4 2024 filings to confirm thesis persistence.

DirectionBullish
Confidencemedium
Horizonweeks

How the stock moved after the report

BULLISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$59.56
T+0 close · Jun 12, 2026 · via day close
Latest settled
+23.24%
T+60 · $73.40
Vs SPY
+19.97%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 12 $59.56entry
  2. T+1 · 5mo ago −0.02%α −1.78% · $59.55
  3. T+5 · 5mo ago +2.55%α +1.88% · $61.08
  4. T+20 · 4mo ago +26.33%α +24.55% · $75.24
  5. T+60 · 2mo ago +23.24%α +19.97% · $73.40

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

A significant institutional cluster formed in CG Oncology during Q3 2024, with 14 buyers accumulating $41.7M in net new positions versus only 3 sellers trimming $5.5M. The buying was dominated by active managers and quant funds, led by Point72's $24.7M increase, suggesting a shared bullish thesis on the company's clinical-stage oncology pipeline.

Key Financial Metrics

Direction
accumulating
Buy Value
$57.8M
Sell Value
$5.5M
Net Flow
$36.2M

Institutional Positions

Net institutional flow: $36.2M

▲ Buyers (14)

InstitutionActionChangePosition ValueValue Δ
Point72DOUBLED+575.7%$28.1M$24.7M
SchwabDOUBLED+114%$14.3M$8.7M
Driehaus Capital ManagementADD+87%$7.5M$4.2M
Rafferty Asset ManagementADD+54.2%$3.0M$1.4M
Rhumbline AdvisersADD+97.4%$2.5M$1.5M

▼ Sellers (3)

InstitutionActionChangePrev ValueValue Δ
CitadelTRIM-34.6%$15.5M-$3.4M
Marshall WaceNEAR_EXIT-89.9%$2.4M-$2.1M
Russell Investments GroupNEAR_EXIT-88.6%$24.0K-$20.9K

Key Facts

  • 14 institutional buyers added $41.7M in net new positions during Q3 2024
  • Point72 (quant) more than 6x'd its stake, adding $24.7M to reach $28.1M
  • Driehaus Capital Management added $4.2M, increasing position 87% to $7.5M
  • Only 3 sellers trimmed $5.5M, led by Citadel reducing $3.4M and Marshall Wace exiting 90% of its $2.1M position
  • Schwab (mega-passive) doubled its position, adding $8.7M to $14.3M
  • Net institutional inflow of $36.2M across the cluster

Financial Impact

14 institutions accumulated $57.8M in holdings (net +$41.7M) while 3 sellers reduced holdings by $5.5M, resulting in a net institutional inflow of approximately $36.2M during Q3 2024

institutional ownershipfloat concentration

Risk Factors

  • 13F data is 45+ days stale; positions may have been unwound since quarter-end
  • Clinical-stage biotech carries binary risk from pipeline trial results
  • Point72's quant strategies can be momentum-driven and may reverse quickly

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
91% bullish (22 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-CGON-2024-Q3

Track record

25 reports on CGON

Performance horizon

5 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +15.20% at T+60 after the Aug 6, 2026 report. 7 of 7 went positive at some point.

Filters
  1. Nov 16, 2026today 8-K Bullish 7/10 Entry $98.84 settles Dec 15
  2. Nov 16, 2026today Press Release Bullish 7/10 Entry $95.01 settles Dec 15
  3. Nov 6, 202610d ago 8-K Bearish 5/10 Entry $75.99 settles Dec 7
  4. Nov 6, 202610d ago Press Release Neutral 4/10 Entry $75.99 settles Dec 7
  5. Nov 3, 202613d ago Institutional Cluster Neutral 3/10 Entry $64.06 settles Dec 2
  6. Oct 19, 202628d ago 3 Neutral 2/10 Entry $61.93 settles Nov 17
  7. Oct 15, 20264w ago 144 Neutral 2/10 Entry $59.85 to $74.40 ▲ +24.31% +25.47% vs SPY
  8. Oct 12, 20265w ago Institutional Cluster Mixed 3/10 Entry $63.13 to $74.74 ▲ +18.39% +21.66% vs SPY
  9. Aug 6, 202614w ago Press Release Bearish 7/10 Entry $74.85 to $74.33 ▲ +0.69% +1.29% vs SPY
  10. Aug 6, 202614w ago 424B5 Bearish 6/10 Entry $74.85 to $74.33 ▲ +0.69% +1.29% vs SPY
Showing 10 of 25

US Market Status

Market Closed · Opens in 6h 22m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 12, 2026